About Us

Albert Einstein College of Medicine, a part of Montefiore

is a premier, research-intensive medical school dedicated
to innovative biomedical investigation and to the
development of Master of Degree in Bronx and
compassionate physicians and scientists. Inspired by the
words of our namesake, we have from our inception
welcomed students, faculty and staff from diverse
backgrounds who strive to enhance human health in the
community and beyond. This is an attribute in which
Albert Einstein took great pride when consenting to the
use of his name in conjunction with the medical school.
At the core of the Einstein-Montefiore mission is the
pursuit of social justice in meeting the healthcare needs
of all individuals, including those from underserved
communities.

Education
Ei stei s M.D. program prepares to orro s physicians to
excel in both the science and the art of medicine by
combining the pursuit of scientific excellence with
compassionate and humanistic care and the social mission to
improve human health through engagement in our local,
national, and global communities. Our Graduate Programs in
the Biomedical Sciences train some of todays brightest
students to become the next generation of leading scientific
researchers, while our Medical Scientist Training Program
(resulting in both M.D. and Ph.D. degrees) embraces a
comprehensive "bench to bedside" philosophy to nurture the
development of well-rounded physician-scientists. In all, the
College of Medicine offers six graduate degree programs.

Research
Boosting Liver DetoxificationThe liver is essential for
removing molecules such as drugs and toxins from the
bloodstreama job done by hepatocytes, cells that comprise
most of the li ers mass and remove these compounds from
the blood using specialized transporter proteins. Allan
Wolkoff, M.D., has received a $2.3 million, five-year renewal
grant from the NIH to continue his research on improving the
li ers detoxification ability. In a healthy liver, these
transporter proteins are in a balanced state as they travel
between the cell surface of hepatocytes and vesicles within
the cells. But disease can disrupt this equilibrium, causing so
few transporters at the cell surface that toxic compounds can
accumulate in the blood.

Health
Editors' Note: February 29 marks the ninth
annual Rare Disease Day, a worldwide event
devoted to raising awareness of more than 6,500
rare diseases, of which less than 5 percent have
any available treatment. In September 2015,
Montefiore assumed operational and financial
control of Einstein. Together they advance clinical
and translational research to accelerate the pace
at which new discoveries become the treatments
and therapies that benefit patients.

Contact Us:-

http://www.einstein.yu.edu/